课题基金 / 基金详情

Mismatch Repair in V region mutation and isotype switch

Mismatch Repair in V region mutation and isotype switch
V区突变和同种型转换中的错配修复
批准号:
7076248
负责人:
MATTHEW D SCHARFF
金额:
$32.66万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-04-30

项目摘要

项目成果

MATTHEW D SCHARFF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Studies in mice that are genetically defective in various mismatch repair proteins strongly suggest that mismatch repair (MMR) plays a major role in the generation of antibody diversity through its affect on somatic hypermutation (SHM) of antibody variable region genes and on class switch recombination (CSR). In addition, deficiencies in MMR predispose to B and T cell malignancies. Studies with of mice MSH2 and MSH6 deficiencies have lead to the hypothesis that SHM and perhaps CSR occur in two phases: one that is AID dependent and results in mutations in G and C in hotspots and a second that depends upon MMR and results in mutations in all bases and is not restricted to hot spot motifs. I propose to test this hypothesis and learn more about the role of MMR by examining mice that are defective in exonuclease 1 or are expressing MMR proteins that have mutations that inactivate their ability to bind ATP. It is possible that the phenotypes of mice lacking MMR activity is partly the reflection of positive and negative selection for B cells making higher affinity or self reactive antibodies. I will therefore also study the role of mismatch repair and dissect out the impact of individual mismatch repair protein by inactivating each of the known MMR proteins and expressing mutant proteins in antibody-forming cells in culture where the positive and negative selection of mutated antibodies will not occur. I will use the MMR repair deficient cells to search for additional proteins that are involve in SHM. These studies should provide new insights into the biochemical mechanisms of SHM and CSR and the role of MMR in predisposing to B cell malignancies and other cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hybridoma (Monoclonal Antibody) Core
  • 批准号:
    7706296
  • 项目类别:
  • 资助金额:
    $36.01万
  • 财政年份:
    2008
  • 负责人:
    MATTHEW D SCHARFF
  • 依托单位:
IMMUNO-ONCOLOGY
PROGRAM LEADERS
Mismatch repair in V region mutation and isotype switching
海外基金